Sara Fazi

Pubblicazioni

Titolo Pubblicato in Anno
 Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo JOURNAL OF TRANSLATIONAL MEDICINE 2022
Extensive histopathological characterization of inflamed bowel in the dextran sulfate sodium mouse model with em-phasis on clinically relevant biomarkers and targets for drug development INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells SCIENTIFIC REPORTS 2021
Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of TH1 and TH2 cells CURRENT OPINION IN PHARMACOLOGY 2021
In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101 INVESTIGATIONAL NEW DRUGS 2020
Curcumin enhances the antitumoral effect induced by the recombinant vaccinia Neu Vaccine (rV-neuT) in mice with transplanted salivary gland carcinoma cells NUTRIENTS 2020
Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials PHARMACOLOGY & THERAPEUTICS 2020
Polyphenol-mediated autophagy in cancer: Evidence of in vitro and in vivo studies INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
Polyphenols as immunomodulatory compounds in the tumor microenvironment: friends or foes? INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019
Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition UROLOGIC ONCOLOGY 2019

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma